Pharma Leaders

Finance to Pharma: Q&A with Renee Aguiar-Lucander

The Calliditas Therapeutics CEO discusses her transition from a banker/investor to CEO of a pharma company.

The Calliditas Therapeutics CEO discusses her transition from a banker/investor to CEO of a pharma company.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]